Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1989 2
1990 2
1991 3
1992 1
1993 3
1996 1
1997 2
1998 3
1999 2
2000 1
2007 1
2008 2
2009 4
2010 8
2011 6
2012 11
2013 9
2014 9
2015 8
2016 12
2017 7
2018 6
2019 16
2020 15
2021 5
2022 14
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Reply.
Sisk RA, Rusia D, Zamora BG, Kuley A, Toussaint BW. Sisk RA, et al. Retina. 2019 Nov;39(11):e47-e48. doi: 10.1097/IAE.0000000000002492. Retina. 2019. PMID: 30845029 No abstract available.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Single-cell profiling reveals inflammatory polarization of human carotid versus femoral plaque leukocytes.
Slysz J, Sinha A, DeBerge M, Singh S, Avgousti H, Lee I, Glinton K, Nagasaka R, Dalal P, Alexandria S, Wai CM, Tellez R, Vescovo M, Sunderraj A, Wang X, Schipma M, Sisk R, Gulati R, Vallejo J, Saigusa R, Lloyd-Jones DM, Lomasney J, Weinberg S, Ho K, Ley K, Giannarelli C, Thorp EB, Feinstein MJ. Slysz J, et al. Among authors: sisk r. JCI Insight. 2023 Sep 8;8(17):e171359. doi: 10.1172/jci.insight.171359. JCI Insight. 2023. PMID: 37471165 Free PMC article.
Pseudohyphema After Recent Pseudophakia.
Christiansen SM, Sisk RA. Christiansen SM, et al. Among authors: sisk ra. Ophthalmology. 2019 Mar;126(3):466. doi: 10.1016/j.ophtha.2019.01.001. Ophthalmology. 2019. PMID: 30803519 No abstract available.
Staphylococcus aureus and its Bearing on Ophthalmic Disease.
Sadaka A, Durand ML, Sisk R, Gilmore MS. Sadaka A, et al. Among authors: sisk r. Ocul Immunol Inflamm. 2017 Feb;25(1):111-121. doi: 10.3109/09273948.2015.1075559. Epub 2015 Dec 17. Ocul Immunol Inflamm. 2017. PMID: 26679534 Review.
Neuropathy target esterase activity predicts retinopathy among PNPLA6 disorders.
Liu J, He Y, Lwin C, Han M, Guan B, Naik A, Bender C, Moore N, Huryn LA, Sergeev Y, Qian H, Zeng Y, Dong L, Liu P, Lei J, Haugen CJ, Prasov L, Shi R, Dollfus H, Aristodemou P, Laich Y, Németh AH, Taylor J, Downes S, Krawczynski M, Meunier I, Strassberg M, Tenney J, Gao J, Shear MA, Moore AT, Duncan JL, Menendez B, Hull S, Vincent A, Siskind CE, Traboulsi EI, Blackstone C, Sisk R, Utz V, Webster AR, Michaelides M, Arno G, Synofzik M, Hufnagel RB. Liu J, et al. Among authors: sisk r. bioRxiv [Preprint]. 2023 Jun 11:2023.06.09.544373. doi: 10.1101/2023.06.09.544373. bioRxiv. 2023. PMID: 37333224 Free PMC article. Updated. Preprint.
154 results